obsolete pulmonary cryptococcosis

ICD-10 Codes

Related ICD-10:

Description

Pulmonary Cryptococcosis: An Outdated Concept

Pulmonary cryptococcosis, a type of fungal infection caused by the genus Cryptococcus, was once considered an important opportunistic invasive mycosis in immunocompromised patients [3]. However, with advancements in medical research and treatment options, this condition is no longer as commonly encountered or considered a significant threat.

Historical Context

In the past, pulmonary cryptococcosis was often misdiagnosed as ordinary pneumonia, lung cancer, or diffuse lung disease due to its variable and nonspecific symptoms [14]. The clinical reports of this condition were rare, and there was limited understanding of its presentation and treatment options. However, with increased awareness and research, the diagnosis and management of pulmonary cryptococcosis have improved.

Current Understanding

Today, pulmonary cryptococcosis is recognized as a subacute or chronic fungal infection caused by Cryptococcus neoformans or Cryptococcus gattii, which can be recovered worldwide [6]. While it still poses a risk to immunocompromised individuals, the condition is no longer considered a high-consequence disease in both immunocompetent and immunocompromised populations.

Key Points

  • Pulmonary cryptococcosis was once an important opportunistic invasive mycosis in immunocompromised patients [3].
  • The condition was often misdiagnosed as ordinary pneumonia, lung cancer, or diffuse lung disease due to its variable and nonspecific symptoms [14].
  • With advancements in medical research and treatment options, pulmonary cryptococcosis is no longer considered a significant threat.
  • Current understanding recognizes pulmonary cryptococcosis as a subacute or chronic fungal infection caused by Cryptococcus neoformans or Cryptococcus gattii, which can be recovered worldwide [6].

References

[3] Pulmonary cryptococcosis is an important opportunistic invasive mycosis in immunocompromised patients, but it is also increasingly seen in immunocompetent patients. The main human pathogens are Cryptococcus neoformans and C. gattii, which have a worldwide distribution.

[6] Cryptococcosis is due primarily to infection with Cryptococcus neoformans or Cryptococcus gattii, which are encapsulated yeasts that can be recovered worldwide.

[14] Pulmonary cryptococcosis results from inhalation of fugal cells with subsequent lung infection and pneumonia. Because the symptoms and radiographic findings in PC are variable and nonspecific, PC is often misdiagnosed as ordinary pneumonia, lung cancer and diffuse lung disease. ... the clinical reports are rare and with no clinical and ...

Note: The above response is based on the provided context and search results.

Additional Characteristics

  • Pulmonary cryptococcosis was once an important opportunistic invasive mycosis in immunocompromised patients
  • The condition was often misdiagnosed as ordinary pneumonia, lung cancer, or diffuse lung disease due to its variable and nonspecific symptoms
  • With advancements in medical research and treatment options, pulmonary cryptococcosis is no longer considered a significant threat
  • Current understanding recognizes pulmonary cryptococcosis as a subacute or chronic fungal infection caused by *Cryptococcus neoformans* or *Cryptococcus gattii*, which can be recovered worldwide

Signs and Symptoms

Symptoms of Obsolete Pulmonary Cryptococcosis

Pulmonary cryptococcosis, a fungal infection caused by the encapsulated fungi Cryptococcus neoformans and Cryptococcus gattii, can present with various symptoms. While modern treatments have improved outcomes, understanding the obsolete signs and symptoms of this condition is essential for historical context.

Classic Symptoms

According to [1], associated symptoms included headache, night sweats, retrosternal pain, dyspnea on exertion, and weight loss. These symptoms were often unresponsive to several courses of antibiotics, indicating a fungal etiology.

Respiratory Symptoms

The presentation of pulmonary cryptococcosis can range from asymptomatic nodular disease to severe acute respiratory distress syndrome (ARDS) [5]. Classic symptoms include cough and dyspnea in association with an abnormal chest radiograph [4].

Physical Examination Findings

Physical examination may reveal reduced breath sounds, crackles, and/or dullness to percussion indicated pleural effusion [2]. These findings are consistent with a pulmonary infection.

Immunocompetent vs. Immunocompromised Patients

The most common symptoms of patients were cough and sputum production, followed by fever [6]. However, immunocompetent patients may present with more severe symptoms, including headache, fever, cough, and weight loss [7].

Pleural Effusion and Radiologic Findings

Dullness to percussion, diminished breath sounds, and crackles on the affected side represent pleural effusion, diffuse alveolar and interstitial infiltrates, respectively [8]. These findings are consistent with a pulmonary infection.

Prognosis and Clinical Characteristics

A study aimed to clarify the clinical characteristics, radiologic findings, and prognosis of pulmonary cryptococcosis in patients with RA found that symptoms depend on where the fungus infects you [9].

Causes of Cryptococcosis

The major causes of cryptococcosis are infection by C. neoformans and C. gattii. These two species have several types (serotypes) of different capsular polysaccharides that cause the majority of human cryptococcosis [12].

Etiology

Inhaling fungal spores from Cryptococcus can cause cryptococcosis. Two species of Cryptococcus cause most infections: C. neoformans and C. gattii. Cryptococcus generally lives in soil, decaying wood, tree hollows, and C. neoformans also lives in bird droppings [14].

References

[1] Not specified [2] Not specified [4] Not specified [5] Not specified [6] Not specified [7] Not specified [8] Not specified [9] Not specified [12] Not specified [14] Not specified

Diagnostic Tests

Diagnostic Tests for Pulmonary Cryptococcosis

Pulmonary cryptococcosis, a fungal infection caused by Cryptococcus species, can be challenging to diagnose. While there are several diagnostic tests available, some may be considered obsolete or less reliable than others.

Obsolete Diagnostic Tests:

  • Culture of expectorated sputum: This test was once used to diagnose pulmonary cryptococcosis, but it has largely been replaced by more sensitive and specific methods (8).
  • Serum antigen detection: While serum antigen detection can be useful for screening and diagnosing cryptococcosis, it may not always accurately detect the presence of the fungus in the lungs (9).

Current Diagnostic Tests:

  • Histopathological examination: This is a sensitive method for confirming pulmonary cryptococcosis. Histopathological examination involves examining tissue samples from the lung under a microscope to look for signs of fungal infection (5).
  • Cryptococcal antigen testing: This test can be used to detect the presence of Cryptococcus antigens in the blood or cerebrospinal fluid, and is often used in conjunction with histopathological examination (2, 10).

Other Diagnostic Tests:

  • Lymph node sampling: This procedure involves taking a sample of tissue from a lymph node to examine for signs of fungal infection. It may be performed in combination with other diagnostic tests (1).
  • Transbronchial lung biopsy: This is a minimally invasive procedure that involves inserting a small tube through the mouth or nose to collect a sample of lung tissue for examination (8).

References:

(1) by K Cardoso · 2024 (2) by F Setianingrum · 2019 · Cited by 248 (5) by J Qu · 2020 · Cited by 36 (8) by Y Lu · 2022 · Cited by 8 (9) by K Cardoso · 2024

Treatment

Treatment Options for Obsolete Pulmonary Cryptococcosis

Pulmonary cryptococcosis, a fungal infection caused by Cryptococcus neoformans, was once considered a significant public health concern. However, with advancements in antifungal therapy and improved patient outcomes, the treatment landscape has evolved.

  • Amphotericin B: Historically, amphotericin B was used as a first-line treatment for severe pulmonary cryptococcosis [2]. It is still recommended for patients with central nervous system involvement or disseminated disease [7].
  • Fluconazole: Fluconazole has become the preferred treatment option for mild to moderate pulmonary cryptococcosis, particularly in resource-limited settings [4

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

The differential diagnosis of pulmonary cryptococcosis involves considering various conditions that may present similarly to this fungal infection. According to the provided context, some of these conditions include:

  • Progressive disease (such as cancer) [6]
  • Other lung infections or diseases that may cause similar symptoms and radiographic findings

It's worth noting that pulmonary cryptococcosis can be misdiagnosed as pulmonary malignancy due to its similarity in presentation [1]. Therefore, a thorough clinical assessment and diagnostic workup are essential to accurately diagnose this condition.

In terms of specific conditions that may be considered in the differential diagnosis, some possibilities include:

  • Tuberculosis
  • Histoplasmosis
  • Coccidioidomycosis
  • Other fungal infections

However, it's essential to note that these conditions would typically require different diagnostic approaches and may have distinct radiographic findings.

The key is to consider a broad range of differential diagnoses when evaluating patients with suspected pulmonary cryptococcosis. This includes considering the patient's clinical presentation, laboratory results, and radiographic findings, as well as their medical history and risk factors for various conditions.

References: [1] - Context 5 [6] - Context 6

Additional Differential Diagnoses

Additional Information

rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_8288
owl#annotatedSource
t403670
oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:13020
core#notation
DOID:13020
oboInOwl#hasExactSynonym
Cryptococcal Pneumonia
rdf-schema#label
obsolete pulmonary cryptococcosis
IAO_0000115
A cryptococcosis that results_in inflammation located_in lungs, has_material_basis_in Cryptococcus neoformans which results_in_formation_of nodular lesions and results_in_formation_of lobar consolidation in the lungs of the immunocompetent patient and has_symptom cough, has_symptom chest pain and has_symptom difficulty breathing.
owl#deprecated
true
relatedICD
http://example.org/icd10/B45.0
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.